Diabetes Clinical Trials in North Carolina

Showing 361-380 of 533 trials

Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes

NCT01933672

Study B1621019 will assess efficacy and safety of two different dosing regimens of an investigational agent (PF-04937319) compared to an approved drug (sitagliptin) in patients with type 2 diabetes

Type 2 Diabetes Mellitus

Pfizer33 participantsStarted Oct 2013

DeLand, Florida, United States • South Miami, Florida, United States • South Miami, Florida, United States +5 more locations

COMPLETEDPhase 331 miles

A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy

NCT01691755

This multicenter, randomized, double-blind, placebo-controlled study will assess the efficacy, safety and tolerability of aleglitazar monotherapy compared with placebo in patients with type 2 diabetes mellitus who have not previously received anti-hyperglycemic therapy. Patients will be randomized to receive oral doses of 150 mcg aleglitazar once daily or placebo. The anticipated time on study treatment is 26 weeks.

Diabetes Mellitus Type 2

Hoffmann-La Roche196 participantsStarted Nov 2012

Chino, California, United States • Los Angeles, California, United States • Santa Ana, California, United States +31 more locations

Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes

A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy

Diabetes Trials in Other Cities

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes

BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).

Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin

Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

Southeastern Diabetes Initiative Clinical Intervention

Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.

Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus

Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes

Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors

Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects

A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes

Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus

A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin

Other Conditions in North Carolina